Hyoscyamine Sulfate 0.375 mg Slow Release Capsules, formulated with Methocel E4M, are designed to gradually release the active ingredient over an extended period. This controlled-release mechanism offers sustained therapeutic effects, reduces dosing frequency, and improves patient compliance. These capsules are used to treat conditions such as Irritable Bowel Syndrome, Gastroesophageal Reflux Disease, Peptic Ulcer Disease, Urinary Incontinence, and Bladder Dysfunction.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Hyoscyamine Sulfate 0.375 mg Slow Release Capsules are a compounded formulation used to treat a variety of conditions such as irritable bowel syndrome, bladder spasms, and peptic ulcers. The medication functions by blocking certain nerve signals in the body, which aids in reducing muscle spasms and decreasing stomach acid production.
This specific formulation is designed with Methocel E4M, a type of controlled-release polymer. This design allows for the gradual release of the encapsulated medication or active ingredient over an extended period of time. This sustained release offers consistent therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications that require a controlled and prolonged release profile.
Patients are advised to take this medication as directed by their healthcare provider. Consistency is key with this medication, so it should be taken at the same time each day to ensure consistent symptom relief. It's important to note that this medication may cause drowsiness, so patients should avoid activities that require alertness, such as driving or operating machinery, while taking it.
Prescribers should be aware that this formulation is not recommended for use in children under the age of 12. Additionally, this medication may interact with other medications, so it's crucial to review the patient's medication list prior to prescribing. If there are any questions or concerns about Hyoscyamine Sulfate 0.375 mg Slow Release Capsules, please reach out to us at Bayview Pharmacy. We are here to assist with any inquiries.
Hyoscyamine Sulfate 0.375 mg Slow Release Capsules are a compounded formulation designed to gradually release the active ingredient over an extended period of time. This is achieved through the use of Methocel E4M, a controlled-release polymer. The slow release of the medication offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.
These capsules may interact with other medications, including anticholinergics, antispasmodics, antihistamines, and tricyclic antidepressants. It is crucial for patients to inform their healthcare provider of all medications they are currently taking, including over-the-counter medications, vitamins, and herbal supplements. Patients should also disclose any allergies they have, especially to hyoscyamine sulfate. Pregnant or breastfeeding individuals should not take Hyoscyamine Sulfate 0.375 mg Slow Release Capsules.
Hyoscyamine Sulfate 0.375 mg Slow Release Capsules can be used to treat a variety of conditions, including irritable bowel syndrome, urinary incontinence, peptic ulcer disease, certain types of spasms associated with Parkinson's disease, abdominal pain, and menstrual cramps. It is essential to follow the healthcare provider's instructions when using this medication. Patients should not exceed the recommended dose and should not take the medication for longer than prescribed.
Potential side effects of Hyoscyamine Sulfate 0.375 mg Slow Release Capsules include dry mouth, blurred vision, dizziness, and constipation. If you have any questions about this medication or any other, please reach out to your healthcare provider or pharmacist.
Hyoscyamine Sulfate 0.375 mg Slow Release Capsules are a specialized formulation designed to treat a range of conditions such as irritable bowel syndrome, bladder spasms, and peptic ulcers. The key ingredient, hyoscyamine sulfate, is encapsulated within a controlled-release polymer, Methocel E4M, which allows for a gradual and sustained release of the medication into the body. This slow release mechanism offers several benefits including sustained therapeutic effects, reduced dosing frequency, and improved patient compliance, particularly for medications requiring a controlled and prolonged release profile.
The slow release of hyoscyamine sulfate ensures a consistent level of medication in the body, reducing the risk of side effects and enhancing the overall effectiveness of the treatment. The medication works by blocking specific receptors in the body that produce chemicals causing symptoms associated with the aforementioned conditions. By inhibiting these receptors, Hyoscyamine Sulfate 0.375 mg Slow Release Capsules can effectively alleviate the symptoms of these conditions.
It is crucial to adhere to the prescribed dosage and frequency when taking Hyoscyamine Sulfate 0.375 mg Slow Release Capsules. Taking more or less than the prescribed amount, or more frequently than advised, can potentially lead to adverse effects. It is also important not to discontinue the medication without consulting your doctor, as abrupt cessation can lead to withdrawal symptoms or a resurgence of the original symptoms.
If you have any queries or concerns about Hyoscyamine Sulfate 0.375 mg Slow Release Capsules, please do not hesitate to contact us. We are committed to helping you understand your medication and how it can assist in managing your condition effectively.
Hyoscyamine Sulfate 0.375 mg Slow Release Capsules are a compounded formulation designed to gradually release the active ingredient over an extended period of time. This is achieved through the use of Methocel E4M, a controlled-release polymer. The slow release of the medication offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
This formulation of Hyoscyamine Sulfate has been used off-label to manage a variety of conditions. These include motion sickness, Parkinson's disease, spasticity, and excessive sweating. It has also been employed to alleviate the symptoms of colic in infants and the symptoms associated with menopause. Furthermore, it has been used to manage symptoms of an overactive bladder, such as frequent urination, urgency, and urge incontinence. It has also been used to alleviate symptoms of gastroparesis, including nausea, vomiting, and abdominal pain.
However, it is crucial to note that the safety and efficacy of Hyoscyamine Sulfate 0.375 mg Slow Release Capsules for these off-label uses have not been definitively established. Therefore, patients and prescribers should engage in thorough discussions about the potential risks and benefits of using this formulation for these off-label uses before initiating treatment. If you have any questions or concerns, please do not hesitate to reach out for further information.
Hyoscyamine Sulfate 0.375 mg Slow Release Capsules is a medication that is encapsulated in a controlled-release polymer, Methocel E4M. This formulation is designed to gradually release the active ingredient over an extended period of time.
Methocel E4M is a type of controlled-release polymer. It is used in this formulation to ensure that the medication is released gradually over a prolonged period, offering sustained therapeutic effects.
A slow-release formulation offers several benefits. It provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications that require a controlled and prolonged release profile.
The dosing frequency of Hyoscyamine Sulfate 0.375 mg Slow Release Capsules is typically less than that of regular medications due to its slow-release formulation. However, the exact frequency will depend on your doctor's prescription.
Hyoscyamine Sulfate is used to treat a variety of stomach and intestinal problems such as cramps and irritable bowel syndrome. It works by decreasing the motion of the stomach and intestines and the secretion of stomach fluids.
No, the Hyoscyamine Sulfate 0.375 mg Slow Release Capsules should not be broken or chewed. Doing so can release all of the drug at once, increasing the risk of side effects. The capsule should be swallowed whole.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Do not double the dose to catch up.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call emergency services immediately. Otherwise, call a poison control center right away.
Before using this medication, tell your doctor or pharmacist if you are pregnant or breastfeeding. This medication should be used only when clearly needed during pregnancy. Discuss the risks and benefits with your doctor.
Side effects may include dry mouth, blurred vision, dizziness, drowsiness, or constipation. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth